LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

i have looked again, and notwithstanding that there are some important and substantial Fruitflow licences imminent, their realisation is surely already anticipated in the share price.

it is also apparent that Barclays Stockbrokers have been the major buyer in recent weeks, with "their" holding increasing for 5% to 8% ..... whether or not this is as a nominee is unclear.

i suppose there is a vague possibility that DSM who already own 27/28% will buy out the balance, but that is lousy logic for buying.

nevertheless, my previous post still holds, though i would consider buying again at +/-7p where chart support could/should come in

Cynic, I agree with what your saying, yes in hind sight i could have sold some and taken a profit, and a very nice one too. And that some shares are for trading , and yes hopefuly making a profit. But this is one of my long term shares so dont worry to much about daily fluctuations, even though they have been large ones re this share, But i think that is always going to be the case along with 99% of all other Aim shares. I have my shares ie some of the banks, tan and others that i trade on small daily moments, So hope that i have a balance. Also with this share as my average is 1.3p. If they didnt get all of the deals and the share fell back to say 5p ,I can still walk away with a nice 400% profit, and if we made 400% on all our shares, we would be very rich people indeed. That might even bring a smile to your face. Anyway good luck with your trading which ever way.

i accept your logic too and also that i rarely hold CFD stocks for more than a few months, so there is a slightly different mental approach ...... however, it is certainly true that shares should not be locked in a drawer and forgotten about ...... it is equally true that one's holding in spivvy/diddy companies (PXS is one such!) should be a very small % of one's portfolio ...... for myself, that why is i am seriously considering lightening my load in CFM as, thanks to the sp gain, it is now (very) o'weight

Courtesy of Foodeagle on iii:-

On 22 June (PXS = 0,9 p), after I had read about the surprising (because Danone, Nestle, Unilever failed so far) success of PXS had at the European Food Safety Authority (EFSA) and after having conducted a thourough research on PXS and its managment, I stated:

"The bad time is over".
http://www.iii.co.uk/investment/detail?code=cotn%3APXS.L&display=discussion&threshold=0&action=detail&id=4992092

The price fell in the weeks after to 0.7 ad briefly even toward 0.55. Believe it or not, I did NOT care at all, because I knew and I still know that neither public, nor media, nor the investment community and not even the all food industry players KNOW what this EFSA ruling means in the context of the new EU Regulation on Health Claims which will be fully implemented next year. This EU Regulation will cause ALL HEALTH CLAIMS on foods and food supplements (!) to be withdrawn from the entire EU market, UNLESS they have positive EFSA ruling. This regulation wil cause the most fundamental changes in the food sector since the BSE crises in the 90s. While joghurts withouth a health claim, will still be eaten (because people like yogurts), but food supplements will be dead without being allowed to tell (advertised, marketed) without being allowed what these capsules/tablets/extracts/powders etc are good for. Yoghurts WITH a health claim are substantial more expensive (Actimel & Activia bring a 20-25 % net margin to Danone!, while normal yogurts rather 12-max 14). Even the immune system claim for Actimel and the bowel claim for Activia will be withdrawn later in 2010, if Danone does not come back again to EFSA and does better than the first time: http://www.nutraingredients.com/Regulation/Danone-bins-EU-probiotic-gut-health-claim-submissions.

Do you think, that Danone will miss some of the 2 bio sales (brutto) and 400 (net) profit annualy from Actimel & Activa ? I think so. I am not surprised that Danone (or another big diary looks for replacement:

"Commercial discussions for Fruitflow continue with potential global license partners for the dairy sector, in addition to further assessment and development work with Coca-Cola." THIS statement is from the annual report of June: http://www.provexis.org/pdfs/Provexis%20plc%20annual%20report%2031-Mar-09%20-%2008-Jun-09%20FINAL.pdf

May it be Danone or another company who is currently approaching Provexis EFSA approved extract. May it be Coke, Unilever or Nestle will establish a profitable collaboration with PXS, it will come. And it will come soon, because we are approaching 2010. In addition to this PXS has announced it is in advanced talks with a top 3 food ingredient producer. Once again, we do not know wether it is Cargil, DSM, BASF or any other (I am confident it is DSM). See my previous postings where I have provided links references to the interview given by Mr. Moon to a Switz Media.

We know that the European Commission is late (like so often) with granting the marketing authorisation to PXS. We also know that this the final issue awaited before these deals with the major food (ingredient) companies will be signed. We also know that this EU approval (wording) will provide further re-assurance into the company, its management and for the stock price. We should all remember that R& D on PXS tomato extract with an effect like Aspirin (but so far without any observed side effects) took many years from the very first steps to the EFSA ruling. We are now awaiting "only" a sheet of paper signed by the EU Health Commissionar Androulla Vassilliou who has put these new rules on "health claims" made on food together with issues like pandemic flu, HIV/AIDS, on the top of her agenda: http://ec.europa.eu/commission_barroso/vassiliou/mypriorities_en.htm This is serious business for the food industry and many of the small and medium companies specialized on functaional foods WILL NOT SURVIVE. On the other sidem those (like PXS) who have pass EFSA will enter in a market, where other food companies will leave because they are not allowed to market with health claim of not approved by EFSA.

Will PXS the only survival of this new EU rules? No, food supplements and foods with vitamines will be allowed to bear claims. We all now that we need vitamines and minerals. They have some function and negative health effects when we lack them.... Who else will stay? Benecol will be allowed, because plant sterols have also reveived a positive EFSA ruling. This EFSA approval on bencol is less valuable because it was NOT an Art 13.5 claim, but "only" an Art 14 claim (every company who produec plant sterols will be allowed to claim this cholesterol lowering effect). Different to PXS, there claim will be protected and exclusive for at least 5 year. Check out by google: EU Regulation 1924/2006, EFSA etc etc "health claims".. These are the rules, which have yet NOT been understood by the investment community.

Who bought PXS in Ausgust ? I am sure at the first 2 weeks mainly those few people like me working in the industry, following the regulatory development. If I have bought, then I am also sure that embloyees from DSM, Unilever and Coke have bought. Some might even know what kind of deals will be signed soon. These people who KNOW what is coming in the next weeks and months amd later in 2010 when the functional food sector in Europe will change fundamentally.

I have talked about the media who will report more and more when we come closer to 2010. They will also report soon after the EU approval of the PXS fruitflow about this one and only product from a small UK university spinn off. Not much later the first deals will be signed. Remember how small PXS is > PXS will have extraordinary high net margins (!) already in 2010.

I wanted to continue, but I am tired (in Switzerland it is already past midnight). Las word of today: even for traders it is now too late to leave this stock. the AMG is approaching THIS week, the EU final marketing approval could come any day now. And following this EU last step, deals will be signed & published. And also the the results of the Asprin vs. fruitflow trial should come soon. I admit, if I had known tha PXS goes to 23 and then down to 9,88, I would have tried to sell high and buy again low. But as previously said, I am not a good trader but I am very familar with the significant regulatory changes in this sector to come in 2010, I have done a thourough research an PXS and its potential partners. I have an idea about the value of this claim and the market if entered with a major like Coke, Danone or Unilever, and I have no doubt that this will happen - rather sooner than later. Maybe days later than some traders and newcomers would have wished, but some months before the investment community realized these regulatory and market changes coming in 2010. Those should sell who really think that the PXS SP will never be higher again than 10, 15 or 20 p ;-))) I am sure it will be.

My strategy remained unchanged despite the disappointing (SP) week. I await the EU approval by the EU Commission and the first big deals with majors. THEN I will have to re-evaluate and to decide to keep, or sell (partly). I will not sell one day before this. Today I have got an opinion from UK that currently "that they want to get the small PI out of this stock". They had last week considerable success, but I will be in, when the above mentioned news will be out.

I have said it on 22 June "the bad time is over" ans the stock x24 on its high and it is still a ten bagger for me. And today, after this week, I say again: the bad time is over !

Thanks for that detailed posting Outlook.

I did bank a profit last week (irresistible!) but will be looking to get back in, preferably below 10p. I reckon the sp could continue to see-saw for a while yet, between now and the EFSA 'piece of paper', and then deals being announced. So: a good stock to 'trade' while keeping some long-term imo.

sorry, but have scanned the above quickly, it seems to me that the author has too great a vested interest to lend much credence to his utterings .... as a PI's opinion fine; as a buy note, far too dodgy

Agreed Toya.

cynic: Your insightful, scientific knowledge is always welcome. Investors flock from far and wide to read it although, strangely, iii & ADVFN seem to get more hits.

lots of words on BBs far too often create false rumour ..... i stand by my comment above even if it does not coincide with your own obviously expert knowledge

for myself, unless there is some truly super-duper news that has yet to be divulged, i shall not repurchase above 7.0/7.25

well its 17% down again, but for those still in the 6p optimistic level is still a further 30% loss from here.

cynic are you back in yet?

bought while en route at 7.25 which was a little rash ..... had i been in front of the screen, i may have hedl off longer

quite amused that the usual abusers have been proved wrong yet again by my Mystic Meg predictions! ...... now hope i don't get too singed .... will serve me right if i do, but can't do myself much damage with these

agree, but bit of a falling knife at present.

indeed so i may well end up regretting trying to catch

Hope you weren't too greedy then Cynic. I was going to set an auto-buy but was around to see it was falling, luckily, or might have bought at 7.50. Anyway, it'll no doubt bounce back soon enough...

Bought some more today.


Sirco that is! From Holland & Barrett. Pomegranate & Orange is my favourite of the two choices. I have to say that is does not look very appetizing but it does taste good. It is not marketed as reducing blood pressure but whether by coincidence or not, it has reduced mine. This has been noted by others on various BB's who have tried it: maybe I can throw my pills in the bin?!

I am quite content to sit on my remaining, now smaller holding of 65k although I do expect a further retracement pending news of a corroboration between PXS and maybe Coca Cola or a similar company; the wording that everyone is waiting for is surely already in the price. Maybe not, who knows?

pending a positive announcement 3-4p might be a fair level.

Yes possibly, it is going to be a "crowd" decision, if you know what I mean.

its hit the optimistic 6p level, a bounce up tomorrow is on the card but would not bet on it. stock may test the 6p brrier and if it breaks through a further fall to 3-4p as mentioned by halifax is more of a possibility. even at 6p the share is 6 times where it started of. so it still has some way down to go.

Decided to jump back in to this "fruit of the loom" thingy on the plunge into the abyss....might not be a good thing but got in just sub 5p....bit of a gamble this...

Time to buy big time chaps and chappesses!